Online Trading Starts Here
EN /persons/dilip-shanghvi/
AR Arabic
AZ Azerbaijan
CS Czech
DA Danish
DE Deutsche
EL Greek
EN English
ES Spanish
ET Estonian
FI Finnish
FR French
HE Hebrew
HI Hindi
HU Hungarian
IND Indonesian
IT Italian
JA Japan
KK Kazakh
KM Khmer
KO Korean
MS Melayu
NB Norwegian
NL Dutch
PL Polish
PT Portuguese
RO Romanian
... Русский
SV Swedish
TH Thai
TR Turkish
UA Ukrainian
UZ Uzbek
VI Vietnamese
ZH Chinese
Dilip Shanghvi

Dilip Shanghvi Net Worth, Biography and Key Insights

$26.6 B Net worth figures are based on publicly available estimates from sources such as Forbes, Bloomberg, and other reputable financial publications. These values are approximate and may not reflect real-time changes. The data is reviewed and updated biannually. Net worth
76 Data is based on Forbes estimates and may not reflect real-time changes. Information is updated twice a year according to the latest Forbes publications. in the world

Dilip Shanghvi’s Profile Summary

Company
Sun Pharmaceuticals
Position
Founder and Managing Director of Sun Pharmaceuticals, one of India’s largest pharmaceutical companies.
Source of wealth
Founder of Sun Pharmaceuticals, investments in renewable energy, strategic acquisitions in the pharmaceutical sector.
Also known as
Investor in renewable energy, philanthropist.
Age
69
Education
University of Calcutta – Bachelor’s degree in Commerce.
Citizenship
Indian
Residence
Mumbai, India
Family
His family includes his wife Vibha Shanghvi and their two children, Aalok and Vidhi Shanghvi.
Website, Social Media
https://sunpharma.com/

Dilip Shanghvi’s biography

Dilip Shanghvi, born on October 1, 1955, in Amreli, Gujarat, India, is an influential figure in the global pharmaceutical industry. He founded Sun Pharmaceuticals in 1983, starting with a modest initial investment and focusing on manufacturing psychiatric drugs. Under his leadership, the company rapidly grew and expanded its product portfolio to include treatments for cardiology, neurology, oncology, and more. Shanghvi’s strategic acquisitions, such as Ranbaxy Laboratories in 2014, propelled Sun Pharmaceuticals to international prominence, making it one of the largest generic drug manufacturers in the world. Known for his calm and thoughtful leadership, Shanghvi has been listed among the wealthiest individuals in India. His impact extends beyond pharmaceuticals, as he has also invested in renewable energy and other sectors. He holds a Bachelor’s degree in Commerce from the University of Calcutta and is recognized for his strategic vision in business growth and expansion.
  • How did Dilip Shanghvi make money?

    Dilip Shanghvi, one of India’s richest entrepreneurs, founded Sun Pharmaceutical Industries in 1983. His entrepreneurial journey began with a small prescription drug business in Kolkata, which he used as a foundation for starting his own company. The initial capital was limited, but Shanghvi focused on manufacturing psychiatric drugs, which were in high demand in India at the time.

    A key milestone in Sun Pharmaceutical’s growth was the introduction of innovations in manufacturing and strategic acquisitions. In 1997, the company entered the US market, which subsequently became its main source of revenue, generating billions of dollars annually. In 2014, Shanghvi acquired Indian pharmaceutical company Ranbaxy Laboratories for $4 billion, significantly increasing its manufacturing capacity and strengthening Sun Pharmaceutical’s position in the international arena.

    Today, Sun Pharmaceutical is one of the largest generic drug manufacturers in the world, with annual revenue exceeding $5 billion. The company's revenues are based on sales of prescription drugs, generics and active pharmaceutical ingredients. Sun Pharmaceutical also actively invests in scientific research, developing new areas such as oncology and ophthalmology.

    Dilip Shanghvi's fortune is estimated at more than $14 billion. His capitalization is based on revenues from Sun Pharmaceutical, which remains a leading player in the global pharmaceutical market.
  • What is Dilip Shanghvi net worth?

    As of 2025, Dilip Shanghvi’s net worth is estimated to be $26.6 B.

What is Dilip Shanghvi also known as?

Dilip Shanghvi has gained recognition for his investments in the renewable energy sector, notably through ventures in wind and solar power projects aimed at reducing India’s carbon footprint. Shanghvi is also known for his philanthropic efforts, focusing on healthcare and education, contributing to various causes and charitable organizations across India.

Prominent achievements of Dilip Shanghvi

Dilip Shanghvi was awarded the Padma Shri in 2016, recognized by Forbes as one of India’s wealthiest individuals, led Sun Pharmaceuticals to become one of the largest pharmaceutical companies globally, completed the significant acquisition of Ranbaxy Laboratories, frequently featured in Forbes’ lists of billionaires and influential business leaders.

What are Dilip Shanghvi’s key insights?

Dilip Shanghvi is known for his patient, long-term approach to business. He emphasizes strategic acquisitions and cost management as key drivers for growth. Shanghvi also believes in empowering his team to take ownership and responsibility for the company's performance, fostering a collaborative and disciplined work culture. His focus is on sustainable growth rather than short-term gains, and he avoids excessive public attention, preferring to let his work speak for itself.

Dilip Shanghvi’s personal life

Dilip Shanghvi is married to Vibha Shanghvi, and they have two children, Aalok and Vidhi. Aalok Shanghvi is involved in the family business, working with Sun Pharmaceuticals, while Vidhi has pursued her own ventures and maintains a relatively low profile in the public eye.

Useful insights

Understanding market forces

Author, Financial Expert at Traders Union

In my experience, to truly succeed as an investor, it’s essential to understand the driving forces behind market behavior. Market movements aren’t random—they’re influenced by a range of economic theories and dynamics. The following books provide valuable insights into these forces, offering a deeper understanding of how global financial markets operate and what shapes their trends.

  • Nassim Nicholas Taleb – "The Black Swan"

    Nassim Nicholas Taleb – "The Black Swan"
    • Summary:

      Taleb explores the concept of rare, unpredictable events—so-called "Black Swans"—that can have massive impacts on markets and society. These events are often overlooked by traditional risk management models, leading to devastating consequences when they occur. Taleb illustrates how these unpredictable shocks shape our world, often more than gradual, expected changes.

    • Why read it:

      This book challenges conventional thinking about risk and uncertainty, showing that many major historical and financial events were "Black Swans." It's a vital read for investors who want to build resilience in the face of market volatility.

  • John Maynard Keynes – "The General Theory of Employment, Interest, and Money"

    John Maynard Keynes – "The General Theory of Employment, Interest, and Money"
    • Summary:

      Keynes revolutionized economics by focusing on total demand within an economy and its effect on output and inflation. His theory suggested that government intervention could stabilize economic cycles through fiscal and monetary policy. The book also explains the consequences of under-consumption and the role of interest rates in managing economic stability.

    • Why read it:

      For investors interested in macroeconomic trends and policy impacts, Keynes’ work is essential. Understanding the Keynesian framework can help investors predict how government actions might influence market performance.

Popular Financial Guides

Latest Financial News